North American Vaccine: 4th strike

When its Certiva diphtheria, tetanus and acellular pertussis (DTaP) vaccine received FDA approval last year, North American Vaccine Inc. hoped that its marketing deal with Abbott Laboratories would allow the product to compete with the three already marketed DTaP vaccines.

But earlier this month, Abbott (Abbott Park, Ill.) terminated its

Read the full 504 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE